We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
-10.28%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.32B
AUM Growth
+$99.8M
(+8.2%)
Cap. Flow
+$327M
Cap. Flow
% of AUM
24.74%
Top 10 Holdings %
Top 10 Hldgs %
52.92%
Holding
77
New
22
Increased
20
Reduced
12
Closed
19
Top Buys
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$86.8M |
| 2 |
RAD
Rite Aid Corporation
RAD
|
+$67.2M |
| 3 |
Penumbra
PEN
|
+$63.2M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
+$52.5M |
| 5 |
Incyte
INCY
|
+$50.3M |
Top Sells
| 1 |
Bausch Health
BHC
|
+$85.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$41.5M |
| 3 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$36.3M |
| 4 |
HCA Healthcare
HCA
|
+$35.4M |
| 5 |
AbbVie
ABBV
|
+$34.3M |
Sector Composition
| 1 | Healthcare | 77.44% |
| 2 | Communication Services | 1.09% |
| 3 | Industrials | 1% |
| 4 | Technology | 0.23% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
26
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $13.9M | 1.05% |
1,028,132
-184,760
| -15% | -$2.5M |
|
|
CFMS
27
DELISTED
Conformis, Inc. Common Stock
CFMS
| $12.4M | 0.94% |
+27,554
| New | +$13.9M |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.1M | 0.84% |
+262,892
| New | +$12.4M |
|
29
Fate Therapeutics
FATE
$347M
| $11.1M | 0.84% |
2,074,836
+67,390
| +3% | +$460K |
|
|
HNT
30
DELISTED
HEALTH NET INC
HNT
| $10.8M | 0.82% |
179,229
-208,899
| -54% | -$13.8M |
|
31
TriNet
TNET
$2.63B
| $10.7M | 0.81% |
+639,186
| New | +$13.1M |
|
|
CASC
32
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $9.9M | 0.75% |
602,498
-91,648
| -13% | -$1.88M |
|
33
ProQR Therapeutics
PRQR
$244M
| $9.63M | 0.73% |
660,816
+144,126
| +28% | +$2.41M |
|
|
BPMC
34
DELISTED
Blueprint Medicines
BPMC
| $7.84M | 0.59% |
367,485
-10,750
| -3% | -$297K |
|
|
TRIV
35
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
| $7.32M | 0.55% |
1,463,983
-580
| -0% | -$3.12K |
|
36
Cerus
CERS
$635M
| $7.28M | 0.55% |
1,603,427
| – | – |
|
37
Neurogene
NGNE
$789M
| $7.24M | 0.55% |
+25,715
| New | +$5.92M |
|
|
ADVM
38
DELISTED
Adverum Biotechnologies
ADVM
| $6.17M | 0.47% |
74,842
+21,114
| +39% | +$2.7M |
|
39
Regenxbio
RGNX
$632M
| $6.1M | 0.46% |
+277,000
| New | +$7.07M |
|
|
DRRX
40
DELISTED
DURECT Corp
DRRX
| $5.1M | 0.39% |
+261,332
| New | +$5.94M |
|
|
INFI
41
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $4.99M | 0.38% |
+590,100
| New | +$5.44M |
|
|
NVTA
42
DELISTED
Invitae Corporation
NVTA
| $4.77M | 0.36% |
660,129
+478,905
| +264% | +$5.03M |
|
|
CSLT
43
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $3.08M | 0.23% |
734,397
-1,250,234
| -63% | -$7.89M |
|
|
CCXI
44
DELISTED
ChemoCentryx, Inc.
CCXI
| $3.03M | 0.23% |
500,615
+24,322
| +5% | +$176K |
|
|
PGND
45
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $2.51M | 0.19% |
+84,966
| New | +$2.59M |
|
|
CARM
46
DELISTED
Carisma Therapeutics
CARM
| $2.04M | 0.15% |
42,418
-20,645
| -33% | -$1.27M |
|
47
Ironwood Pharmaceuticals
IRWD
$660M
| $1.99M | 0.15% |
+227,802
| New | +$2.13M |
|
|
NVRO
48
DELISTED
NEVRO CORP.
NVRO
| $1.16M | 0.09% |
+25,000
| New | +$1.21M |
|
|
GNCA
49
DELISTED
Genocea Biosciences, Inc.
GNCA
| $628K | 0.05% |
11,456
-66,484
| -85% | -$6.59M |
|
50
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $576K | 0.04% |
+9,250
| New | +$729K |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO